Guido Guidi
Direktor/Vorstandsmitglied bei GENENTA SCIENCE S.P.A.
Vermögen: 188 067 $ am 30.04.2024
Aktive Positionen von Guido Guidi
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
GENENTA SCIENCE S.P.A. | Direktor/Vorstandsmitglied | 01.01.2017 | - |
Independent Dir/Board Member | 01.01.2017 | - | |
PHILOGEN S.P.A. | Direktor/Vorstandsmitglied | 13.05.2019 | - |
RECORDATI | Direktor/Vorstandsmitglied | 29.04.2020 | - |
Corporate Officer/Principal | 29.04.2020 | - | |
Cellestia Biotech AG
Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland. | Vorsitzender | - | - |
Geleven SRL | Vorstandsvorsitzender | - | - |
Aurora Science Srl
Aurora Science Srl Investment ManagersFinance Aurora Science, invests in Italian startups. The fund invests in health technology with particular interest for biotech and pharmaceuticals. It provides equity financing for early stage investing between EUR 1 to EUR 5 million. | Gründer | - | - |
Vorsitzender | - | - | |
Direktor/Vorstandsmitglied | - | - | |
Tethis SpA
Tethis SpA BiotechnologyHealth Technology Tethis SpA engages in the provision of nanobiotechnology solutions. It develops devices for liquid biopsy, molecular diagnostic, and proteomic and microbiology. The company was founded by Emanuele Barborini, Simone Vinati, and Massimo Gatelli in 2004 and is headquartered in Milan Italy. | Direktor/Vorstandsmitglied | - | - |
Zambon SpA
Zambon SpA Pharmaceuticals: MajorHealth Technology Zambon SpA is engaged in manufacturing pharmaceutical products. It offers anauran, anaurette, asacol, codex, fluimucil, and giason. The company is headquartered in Bresso, Italy. | Direktor/Vorstandsmitglied | - | - |
Italfarmaco SpA
Italfarmaco SpA Pharmaceuticals: MajorHealth Technology Italfarmaco SpA engages in the production and distribution of pharmaceutical and fine chemical products. It also provides research and development, scientific publishing, business development, and licensing services. The company was founded in 1938 and is headquartered in Milan, Italy. | Corporate Officer/Principal | - | - |
░░░░░░ ░░ ░░░ | ░░░░░░░░ | - | - |
░░░░░░░ | - | - |
Karriereverlauf von Guido Guidi
Ehemalige bekannte Positionen von Guido Guidi
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
░░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░ ░░ | ░░░░░░░░ | - | - |
░░░░░░░░ ░░░░░░░░░░░░░ ░░ | ░░░░░░░░ | - | - |
░░░░░░░░ ░░ ░░░░ | ░░░░░░░░ | - | - |
Ausbildung von Guido Guidi
University of Milan | Undergraduate Degree |
Statistik
International
Italien | 14 |
Vereinigtes Königreich | 2 |
Spanien | 2 |
Operativ
Director/Board Member | 6 |
Chairman | 6 |
Corporate Officer/Principal | 4 |
Sektoral
Health Technology | 11 |
Consumer Services | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
GENENTA SCIENCE S.P.A. | Health Technology |
PHILOGEN S.P.A. | Health Technology |
RECORDATI | Health Technology |
Private Unternehmen | 13 |
---|---|
Tethis SpA
Tethis SpA BiotechnologyHealth Technology Tethis SpA engages in the provision of nanobiotechnology solutions. It develops devices for liquid biopsy, molecular diagnostic, and proteomic and microbiology. The company was founded by Emanuele Barborini, Simone Vinati, and Massimo Gatelli in 2004 and is headquartered in Milan Italy. | Health Technology |
Italfarmaco SpA
Italfarmaco SpA Pharmaceuticals: MajorHealth Technology Italfarmaco SpA engages in the production and distribution of pharmaceutical and fine chemical products. It also provides research and development, scientific publishing, business development, and licensing services. The company was founded in 1938 and is headquartered in Milan, Italy. | Health Technology |
Zambon SpA
Zambon SpA Pharmaceuticals: MajorHealth Technology Zambon SpA is engaged in manufacturing pharmaceutical products. It offers anauran, anaurette, asacol, codex, fluimucil, and giason. The company is headquartered in Bresso, Italy. | Health Technology |
Novartis UK Ltd.
Novartis UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis UK Ltd. is an international pharmaceutical company. It strives to discover ways to improve and extend people’s lives. The company is headquartered in Frimley, the United Kingdom. | Health Technology |
Novartis Farmacéutica SA | |
Sandoz SpA
Sandoz SpA Pharmaceuticals: MajorHealth Technology Sandoz SpA manufactures pharmaceutical products. It develops and distributes medicines for cardiovascular systems, antibiotics, antidepressants, anti-asthmatics, calcium compounds, and laxatives. The company is headquartered in Origgio, Italy. | Health Technology |
Elanco Italia SpA
Elanco Italia SpA Pharmaceuticals: MajorHealth Technology Elanco Italia SpA operates as a global health company. It provides products, services and knowledge to prevent and treat farmed and companion animal diseases in more than 90 countries. The company is headquartered in Sesto Fiorentino, Italy. | Health Technology |
Novartis Norge AS
Novartis Norge AS Miscellaneous Commercial ServicesCommercial Services Novartis Norge AS develops, markets, and trades pharmaceuticals. It offers ophthalmic and generic products. The company is headquartered in Oslo, Norway. | Commercial Services |
Aurora Science Srl
Aurora Science Srl Investment ManagersFinance Aurora Science, invests in Italian startups. The fund invests in health technology with particular interest for biotech and pharmaceuticals. It provides equity financing for early stage investing between EUR 1 to EUR 5 million. | Finance |
Sharper Italia | |
Geleven SRL | |
Cellestia Biotech AG
Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland. | Health Technology |
Aurora Tt SRL |
- Börse
- Insiders
- Guido Guidi
- Erfahrung